Myanmar vs Timor-Leste: Incidence of tuberculosis
Incidence of tuberculosis over time
- Myanmar
- Timor-Leste
How they compare
Timor-Leste currently reports 496 per 100,000 people against 482 per 100,000 people in Myanmar, a difference of 14 per 100,000 people.
The two have swapped places 2 times across 23 shared years of data; in 2002 it was Timor-Leste ahead.
Myanmar ranks 7th and Timor-Leste ranks 5th of 208 countries.
Timor-Leste has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 541.25 per 100,000 people | 925.62 per 100,000 people | 384.38 per 100,000 people | Timor-Leste |
| 2010s | 404.9 per 100,000 people | 485 per 100,000 people | 80.1 per 100,000 people | Timor-Leste |
| 2020s | 413.4 per 100,000 people | 430.4 per 100,000 people | 17 per 100,000 people | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Myanmar or Timor-Leste?
- Timor-Leste, at 496 per 100,000 people against 482 per 100,000 people in Myanmar as of 2024.
- What is the difference in incidence of tuberculosis between Myanmar and Timor-Leste?
- 14 per 100,000 people, with Timor-Leste ahead.
- How many years of comparable data are there for Myanmar and Timor-Leste?
- 23 years are reported by both, from 2002 to 2024.
- How do Myanmar and Timor-Leste rank globally for incidence of tuberculosis?
- Myanmar ranks 7th and Timor-Leste ranks 5th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.